RxDoctor Payments Data

Gary McPhail

Pediatric Pulmonology · Cincinnati, OHNPI 1821027483

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (44.1%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. Boehringer Ingelheim accounts for 62.6% of it on its own, with 3 other manufacturers making up the rest.

$1,572in general payments, 2019–2025

Across 10 payments — averaging $157.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boehringer Ingelheim$984
  • Vertex$555
  • Alcresta Therapeutics, Inc.$18
  • AbbVie$16
$1,081,260in research payments, 2019–2025

Across 59 payments — averaging $18,326 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Vertex$1.1M
  • Boehringer Ingelheim$17K
  • Boehringer Ingelheim France S.a.s.$3K
  • Boehringer Ingelheim International GmbH$861

What the payments were for

  • Consulting fees$55535%
  • Travel & lodging$69444%
  • Food & beverage$32421%

General payments by program year

19
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,572 in reported general payments places this provider in the 75th percentile of 68 pediatric pulmonology providers in Ohio.

See all pediatric pulmonology providers in Ohio →

Other pediatric pulmonology in Cincinnati

See the full list for Ohio →

Where these figures come from

Is this you, or does something look wrong? →